Surface Oncology, Inc, based in Cambridge, is a pioneering biotechnology company focused on developing cutting-edge immunotherapies.
Their innovative approach targets the immune-suppressive tumor microenvironment to effectively combat cancer, offering hope for improved treatment outcomes.
Generated from their website's infomation